|
|
Volumn 14, Issue 4, 2000, Pages 468-469
|
|
The development of lipodystrophy on a protease inhibitor-sparing highly active antiretroviral therapy regimen
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ABDOMINAL DISTENSION;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERLIPIDEMIA;
INSULIN RESISTANCE;
LACTIC ACIDEMIA;
LETTER;
LIPID METABOLISM;
LIVER DISEASE;
META ANALYSIS;
OBESITY;
PRIORITY JOURNAL;
ANTI-HIV AGENTS;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
LIPODYSTROPHY;
REVERSE TRANSCRIPTASE INHIBITORS;
|
|
EID: 0034070196
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200003100-00026 Document Type: Letter |
|
Times cited : (13)
|
|
References (9)
|
